Bloodline
Education
Resources
Supported by:
|
|
Bloodline UpdatesHematology News |
||||||||||||||||||||||||||||||||||||||||||||||||||
The content of this continuing medical education (CME) activity is derived from a symposium, “The Promise of Epigenetic Therapy,” presented at the 48th Annual Meeting of the American Society of Hematology.
Graft-versus-host disease (GvHD) is a common side effect of an allogeneic bone marrow or cord blood transplant. This program discusses the results of treating chronic GvHD with extracorporeal photopheresis.



